Thailand Medicinal Cannabis Card Service Logo

ROYAL GAZETTE DOCUMENTS

Page 45

Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

Royal Gazette volume 140, special part 130 ง, page 45, 2 June B.E. 2566 (2023).

Notification of the National Drug System Development Committee on the National List of Essential Medicines (Herbal) B.E. 2566.

In order to drive and promote the use of herbal medicines in the health-service system in a concrete way, to promote wisdom so that it is developed further by using resources available in the country to the highest benefit through systematic research and development of herbal medicines, so that Thailand can rely on itself and to strengthen the country’s medicine security, which is in accordance with the provisions of the Constitution, and in order that the herbal national essential medicines list is revised to keep pace with present circumstances.

By virtue of ข้อ 8 (4) of the Office of the Prime Minister Regulation on the National Drug System Development Committee B.E. 2551, the National Drug System Development Committee hereby issues the Notification as follows.

ข้อ 1 The following are repealed: (1) the Notification of the National Drug System Development Committee on the National List of Essential Medicines (Herbal) B.E. 2564 dated 25 November B.E. 2564; (2) the Notification of the National Drug System Development Committee on the National List of Essential Medicines (Herbal) (No. 2) B.E. 2565 dated 13 September B.E. 2565.

ข้อ 2 The list of herbal medicines in the schedule annexed to this Notification shall be used as medicines on the herbal national essential medicines list.

ข้อ 3 This Notification shall come into force from the day after the date of its publication in the Royal Gazette onwards.

Given on 10 May B.E. 2566. Anutin Charnvirakul, Deputy Prime Minister, Chair of the National Drug System Development Committee.

The list of herbal medicines that are items on the herbal national essential medicines list under this Notification means herbal medicines for use in hospitals and public-health service facilities, with properties or indications as approved by the agency having legal power, or herbal medicines that are hospital pharmacopoeia formulas (รพ.) exempted by law, or that are under a project approved by the Sub-committee on Development of the Herbal National Essential Medicines List. It comprises three sub-lists: the basic list, the specific list, and the special list.

The basic list means medicines that a professional practitioner may order for use generally.

The specific list means medicines that require diagnosis and ordering by a Thai traditional medicine practitioner, or an applied Thai traditional medicine practitioner, or a modern-medicine doctor who has completed training, or a person assigned by the director of that medical facility.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

The special list means medicines for which scientific empirical evidence is limited and for which effectiveness and safety must be followed up in order to review the status of the item on the herbal national essential medicines list at least every 6 months, or when there is new scientific empirical evidence that differs from what was previously considered. A special-list item must have a responsible agency for the project and the budget, a written project with an executive summary, rationale, objectives, method, a clear start and end, specified specific health benefits or clinical indication and method of use, a plan to follow effectiveness and safety with safety reports to the Health Product Vigilance Center for every case found, a plan to follow the patient’s cooperation in using the medicine, and a letter of intent to take responsibility and support the budget from a state agency. Results must be reported to the Sub-committee every 6 months, or when new evidence arises, and at the end of the project.

The herbal-medicine items consist of the name, dosage form, properties or indications, and sub-list, as in Appendix 1, with the ingredients of each formula and the details of each item as in Appendix 2.

“Hospital form (รพ.)” after a dosage form means a form produced by a medical facility under a ministry, bureau, or department that has the duty to prevent or treat disease. Appendix 1 and Appendix 2 also list many herbal medicines that do not contain cannabis, grouped by symptom. The cannabis items are set out below as printed.

Group 2.4, medicines to relieve haemorrhoids. 1. Turmeric-and-cannabis topical medicine. Dosage form: oil, or powder for mixing in oil (รพ.). Basic list. Indication: treat haemorrhoids.

Group 2.6, medicines to relieve nausea and vomiting. 2. Cannabis extract oil containing delta-9-tetrahydrocannabinol (THC), two strengths, namely not more than 0.5 milligrams per drop and not more than 3 milligrams per drop. Dosage form: oromucosal drops. Specific list. Indication: use as adjunct or combined with standard treatment of nausea and vomiting from chemotherapy.

Group 7, musculoskeletal. 2. Ya kae lom kae sen. Dosage form: powder. Specific list. Indication: treat wind in the channels; relieve muscle pain with numbness of the hands and feet. 11. Five-part cannabis oil. Dosage form: oromucosal drops. Basic list. Indication: use as adjunct treatment in a patient with muscle and joint pain in whom standard medicine has not been effective. 12. Cannabis extract oil containing THC and CBD in the ratio 1:1. Dosage form: oromucosal drops. Specific list. Indication: use as adjunct treatment in progressive multiple sclerosis with spasticity.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

Group 13 includes Ya ammarit osot, specific list, indication: treat wind kasa; relieve chronic tight muscle ache. The formula in Appendix 2 contains 10 grams of cannabis inflorescence.

Group 14, brain and nervous system. 1. Cannabis extract oil containing cannabidiol (CBD) 100 milligrams per millilitre and delta-9-tetrahydrocannabinol (THC) in a CBD:THC ratio greater than or equal to 20:1. Dosage form: oromucosal drops. Special list. Indications: 1. difficult-to-treat epilepsy; 2. epilepsy that is resistant to treatment.

Group 15, other. 1. Five-part cannabis oil. Dosage form: oromucosal drops. Basic list. Indication: use as adjunct treatment in a patient with insomnia in whom standard medicine has not been effective. 2. Cannabis oil produced from the flower, which has THC 2.0 milligrams per millilitre. Dosage form: oromucosal drops, including hospital form (รพ.). Basic list. Indications: relieve chronic pain, help sleep, help appetite, in a patient diagnosed with cancer. 3. Cannabis extract oil containing THC and CBD in the ratio 1:1. Dosage form: oromucosal drops. Specific list. Indication: use as adjunct treatment in a patient with terminal cancer who has insomnia, loss of appetite, or moderate-to-severe pain that standard medicine cannot treat or has not treated effectively. 4. Cannabis extract oil containing THC, two strengths, namely not more than 0.5 milligrams per drop and not more than 3 milligrams per drop. Dosage form: oromucosal drops. Specific list. Indication: the same terminal-cancer adjunct use as item 3. 5. Ya prasakanya. Dosage form: capsules, powder (รพ.), capsules (รพ.). Specific list. Indication: help sleep. 9. Ya suk sai-yat. Dosage form: capsules, powder. Specific list. Indication: help sleep and appetite.

(1) Turmeric-and-cannabis topical medicine. Oil, or powder for mixing in oil (รพ.). Basic list. Formula: 30 grams of powder prepared from 15 grams turmeric rhizome and 15 grams cannabis leaf, to be mixed with 30 grams cottonseed oil. Indication: treat haemorrhoids. Use: mix the powder with the oil until uniform; apply twice a day after bathing, morning and evening. Caution: use with care in a person allergic to an ingredient. Adverse effects: may cause skin irritation, itching, redness, or heat. Additional: in practice the powder-for-mixing form is dispensed with cottonseed oil for the patient to prepare freshly. Take care that the medicine does not stain clothing.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

(2) Cannabis extract oil containing THC, two strengths: not more than 0.5 milligrams per drop and not more than 3 milligrams per drop. Oromucosal drops. Specific list. Conditions of use: 1. For adjunct or combined use with standard treatment of nausea and vomiting from chemotherapy, it shall be ordered by a modern-medicine practitioner concerned with ordering chemotherapy for treatment, who has completed a medical-cannabis training course recognised by the Ministry of Public Health. 2. The 3 milligrams-per-drop strength: 2.1 helps convenience for a patient who must use the not-more-than-0.5 milligrams-per-drop oil in a high quantity; 2.2 is for a patient who has previously used the not-more-than-0.5 milligrams-per-drop oil and already knows the appropriate quantity, only.

Formula: extract of cannabis (Cannabis sativa L.) with the active substance delta-9-tetrahydrocannabinol not more than 0.5 milligrams per drop or not more than 3 milligrams per drop. Indication: adjunct or combined with standard treatment of nausea and vomiting from chemotherapy. Dose: for THC not more than 0.5 milligrams per drop, 1 drop under the tongue (THC 0.5 milligrams) every day at bedtime, adjust every 48 hours slowly, maximum not more than 10 drops a day (THC 5 milligrams a day). For THC not more than 3 milligrams per drop, 1 drop under the tongue (THC 3 milligrams) every day at bedtime; for a person who has used the 0.5 milligrams-per-drop oil, calculate an equivalent THC quantity, maximum not more than 20 milligrams a day.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

Contraindications: a person who has been allergic to cannabis; a person with severe cardiovascular disease or severe cerebrovascular disease, because it may cause low blood pressure, and sometimes high blood pressure, fainting, abnormal rapid heartbeat, myocardial infarction, and cerebrovascular disease; a person with schizophrenia or bipolar disorder. Warnings: should not be used in a person under 25 years except where the doctor considers the benefit greater than the risk; avoid in a pregnant woman, a breastfeeding woman, and a woman of childbearing age who is not using contraception or who plans pregnancy; may cause drowsiness, so the person should not drive a vehicle or work with machinery or do dangerous work; avoid with alcoholic drinks. Interactions: take care with medicines metabolised through CYP2C9, CYP2C19, or CYP3A4, for example amiodarone, carbamazepine, phenytoin, warfarin, or valproic acid; take care with highly protein-bound medicines, for example warfarin, cyclosporine, and amphotericin B. Cautions: severe liver or kidney impairment; avoid long-term ordering and follow signs of dependence; before stopping, reduce the dose gradually to prevent withdrawal; take care with sedatives or other psychoactive medicines because of added central-nervous-system depression or psychoactive effects; take care in a person with a history of substance use including alcohol dependence. Additional: cannabis consumption by a man may affect fertility because THC may make the seminal vesicles smaller, reduce semen, and reduce sperm production. Adverse effects: dry mouth, dry throat, dizziness, drowsiness, euphoria, nausea, vomiting, blurred vision, hallucination, cognitive impairment.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

(2) Ya kae lom kae sen. Powder. Specific list. Condition: order by a Thai traditional medicine practitioner, or an applied Thai traditional medicine practitioner, or a person assigned by the director of that medical facility, using Thai traditional medicine knowledge. Formula, in 150 grams: pepper seed 80 grams, cannabis leaf 40 grams, jet-mun-phloeng root 10 grams, ginger rhizome 8 grams, fennel 6 grams, black cumin 4 grams, white cumin 2 grams. Indication: treat wind in the channels; relieve muscle pain with numbness of the hands and feet. Dose: 1 to 4 grams each time, twice a day before meals, morning and evening. Vehicle: 1 teaspoon (5 cc) of comb honey or kaffir-lime juice; if that vehicle cannot be found, use half a glass (60 cc) of boiled water. Advice: increase the dose gradually; comb honey or kaffir-lime juice as vehicle helps reduce adverse effects. Contraindications: pregnant woman, breastfeeding woman, a person with fever. Cautions: peptic ulcer and gastro-oesophageal reflux, because it is a hot-taste formula; for a diabetic patient use boiled water as vehicle. Adverse effects: may cause dizziness, confusion, dry throat, burning in the chest. Additional: wind in the channels is wind that regularly blows along the various channels of the body, for example chantha-kala wind in the ita channel and suntha-kala wind in the pingkhala channel; when those winds are abnormal the patient has pain or numbness along the channel where that wind regularly blows, or nearby.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

(24) and Group 13 (3) Ya ammarit osot. Powder (รพ.), capsules (รพ.). Specific list. Formula, 76 grams of powder or capsules from: 1 gram each of sahatsakhun stem, samae-thalay heartwood, somkung root, bael fruit, terminalia belerica fruit, philangkasa fruit, terminalia chebula fruit (foreign), terminalia chebula fruit (Thai), kot khema, black cumin, white cumin, nutmeg, mace, cardamom, clove, long pepper; 3 grams each of burnt khong-shell, burnt khom-shell, burnt cockle shell, and burnt cowrie; 10 grams cannabis inflorescence; 38 grams pepper fruit. Indication: treat wind kasa; relieve chronic tight muscle ache. Dose: 1 to 2 grams each time, twice a day before meals, morning and evening. Vehicle: half a glass (125 cc) of boiled water. Note: start at a low dose and increase. Contraindications: pregnant woman, breastfeeding woman, a person with fever, and a person in early childhood (under 16 years). Cautions: anticoagulants and antiplatelets; phenytoin, propranolol, theophylline, and rifampicin because the formula is high in pepper; hypertension that cannot be controlled, arrhythmia that cannot be controlled, peptic ulcer, gastric disease, and reflux, because it is a hot-taste formula; elderly patients; may cause drowsiness, so avoid driving or machinery. Adverse effects: dizziness, burning stomach, drowsiness, dry mouth, dry throat.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

(5) Ya prasakanya. Capsules, powder (รพ.), capsules (รพ.). Specific list. Formula, in 2,000 grams of powder: 125 grams each of dried ginger rhizome, long pepper, red or white sandalwood heartwood, neem leaf, khonthi-khema leaf; 250 grams hulled pepper seed; 1,000 grams cannabis leaf. Indication: help sleep. Dose: 1 to 2 grams at bedtime; start low and increase. Vehicles include coconut water, comb honey, kaffir-lime juice, sugar, fresh krachai, and bencha-thapthim water, chosen to suit the patient’s disease or symptoms, for example coconut water, comb honey, or sugar if weak; kaffir-lime juice if phlegm in the throat; fresh krachai water if indigestion, bloating, or flatulence; boiled bencha-thapthim water if diarrhoea; if no vehicle can be found, half a glass (60 cc) of boiled water. Contraindications: pregnant woman, breastfeeding woman; do not use with central-nervous-system depressants such as sleeping medicines or anticonvulsants; do not use with alcohol or anything containing alcohol, because of central-nervous-system depression. Cautions: anticoagulants and antiplatelets; may cause drowsiness, so avoid driving or machinery; take care with other Thai traditional formulas that contain cannabis. Additional: recommended in a person who cannot eat and cannot sleep. The Ayurvedic Study text of Khun Nithet Sukkit, item 2514, and the Medical Science Assistance text R.S. 128, page 476, print the same formula as treating yellow wasting fever without strength, trembling body and voice from aggravated vata, and sleeplessness, with trikatu, both sandalwoods, neem leaf, khonthi-khema leaf, hulled pepper in equal parts, and cannabis leaf equal to all those medicines, made into powder and taken dissolved in coconut water, honey, kaffir-lime juice, sugar, fresh krachai, or boiled bencha-thapthim water.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

(9) Ya suk sai-yat. Capsules, powder. Specific list. Condition: order by a Thai traditional medicine practitioner, or an applied Thai traditional medicine practitioner, or a person assigned by the director of that medical facility, using Thai traditional medicine knowledge. Formula, in 78 grams: cannabis leaf 12 grams, long pepper 11 grams, dried ginger rhizome 10 grams, pepper seed 9 grams, bunnak flower 8 grams, nutmeg 7 grams, kot kraduk 6 grams, black cumin 5 grams, samunwaeng bark 4 grams, hatsakhun-thet 3 grams, neem leaf 2 grams, camphor 1 gram. Indication: help sleep and appetite. Dose: for insomnia, 0.5 to 2 grams once a day at bedtime; for loss of appetite, 0.5 to 2 grams one to two times a day before meals. Vehicle: 1 teaspoon (5 cc) of comb honey; if that cannot be found, half a glass (60 cc) of boiled water. Contraindications: pregnant woman, breastfeeding woman, a person with fever. Cautions: continuous use especially in a patient with liver or kidney abnormality, because camphor may accumulate and cause toxicity; peptic ulcer and reflux, because it is a hot-taste formula; central-nervous-system depressants such as sleeping medicines and anticonvulsants, and alcohol; for a diabetic patient use boiled water as vehicle. Adverse effects: may cause dry mouth, dry throat, flushed face.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

(11) Five-part cannabis oil, Group 7. Oromucosal drops. Basic list. Formula: in 5 millilitres of oil obtained by simmering 312.5 milligrams each of cannabis root, stem including twigs, leaf, and inflorescence including seed, in coconut oil, containing THC 0.1 to 0.4 milligrams per millilitre and CBD less than 0.04 milligrams per millilitre. Indication: adjunct treatment in a patient with muscle and joint pain in whom standard medicine has not been effective. Dose: start 2 drops under the tongue twice a day before meals, morning and evening, or as the doctor orders; may increase by 1 to 2 drops, given 3 to 4 times a day, 6 to 8 hours apart, increasing every 3 to 7 days under a doctor’s advice until a treatment effect is seen without adverse effects; THC over 20 milligrams a day is not recommended. Contraindications: history of allergy to cannabis or coconut oil; history of psychiatric abnormality; severe or uncontrolled cardiovascular disease; a person using warfarin; pregnant woman; breastfeeding woman; a person under 16 years (early childhood). Warnings: if the patient has confusion, agitation, anxiety, hallucination, or other psychiatric abnormality, stop at once and follow closely until the symptoms go; may cause dry mouth and dry throat in the first week, water may be drunk about 10 minutes after the dose. Interactions: substrates, inducers, or inhibitors of CYP2C9, CYP2C19, CYP3A4, CYP2D6, CYP1A; medicines often used with cannabis that add effect, for example phenobarbital, phenytoin, topiramate, protease inhibitors such as indinavir, nelfinavir, saquinavir, CYP3A4-inhibitor antivirals such as indinavir, ritonavir, saquinavir, and central-nervous-system depressants such as morphine analgesics and sleeping medicines. Cautions: liver and kidney abnormality; sedatives or other psychoactive medicines; driving, machinery, or dangerous work because of drowsiness; history of substance use including nicotine, or heavy drinking. Adverse effects: dry mouth, dry throat, dizziness, drowsiness, rapid heartbeat, nausea. Additional: the former name under the B.E. 2564 list was cannabis oil produced from root, stem, twigs, leaf, flower, and seed, which was on list 3 under a special project of Chao Phraya Abhaibhubejhr Hospital; the Committee later approved moving it from list 3 to list 1.1 (basic list) because it had effectiveness and safety and could be ordered generally, and renamed it five-part cannabis oil for ease of memory.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

(12) Cannabis extract oil containing THC and CBD in the ratio 1:1, Group 7. Oromucosal drops. Specific list. Condition: order by a modern-medicine practitioner who has completed a medical-cannabis training course recognised by the Ministry of Public Health. Formula: extract of cannabis (Cannabis sativa L.) with THC 27 milligrams per millilitre and CBD 25 milligrams per millilitre. Indication: adjunct treatment in progressive multiple sclerosis with spasticity. Dose: 1 drop on the sublingual mucosa (THC 1 milligram and CBD 1 milligram) at bedtime; if after 15 minutes it has not been effective, another drop may be added; if more than 2 drops a day, divide into morning and bedtime; should not exceed 30 drops a day (THC 30 milligrams and CBD 30 milligrams). Contraindications: previous cannabis allergy; history of psychiatric abnormality in the person or family; uncontrolled cardiovascular disease; a person under 16 years. Warnings: if confusion, visual hallucination, suicidal thought, or other psychiatric symptoms, stop at once and follow closely; may cause mild or moderate dizziness, often in the first 2 to 3 weeks. Interactions: substrates, inducers, or inhibitors of CYP3A4, CYP2C19, CYP2C9, CYP1A2, P-glycoprotein, BCRP, and MRP1; may reduce the effectiveness of contraceptives; may add to muscle relaxants such as baclofen and benzodiazepines, increasing fall risk. Cautions: history of seizure or recurrent seizure; liver and kidney abnormality; pregnant woman or a woman planning pregnancy, breastfeeding woman. Adverse effects: dizziness, nausea, vomiting, confusion, fatigue, drowsiness, dry mouth, diarrhoea.

(1) Cannabis extract oil containing CBD 100 milligrams per millilitre and THC in a CBD:THC ratio greater than or equal to 20:1, Group 14. Oromucosal drops. Special list. Condition of use: use according to a project of the Department of Medical Services only. Indications: 1. difficult-to-treat epilepsy; 2. epilepsy that is resistant to treatment.

(1) Five-part cannabis oil, Group 15. Same formula as the Group 7 five-part oil. Basic list. Indication: adjunct treatment in a patient with insomnia in whom standard medicine has not been effective. Dose: start 2 drops under the tongue once a day at bedtime, or as the doctor orders, with the same titration, interval, and THC-not-over-20 milligrams-a-day recommendation, contraindications, warnings, interactions, cautions, and adverse effects as the Group 7 five-part oil, and the same additional note on the former name and the move from list 3 to the basic list.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

(2) Cannabis oil produced from the flower, which has THC 2.0 milligrams per millilitre. Oromucosal drops, including hospital form (รพ.). Basic list. Formula: cannabis extract in coconut oil at 10 percent of the dry-flower weight, with THC 2.0 milligrams per millilitre. Indication: relieve chronic pain, help sleep, help appetite, in a patient diagnosed with cancer. Dose: 1 drop by mouth at bedtime, or according to the judgment of the Thai traditional medicine practitioner, applied Thai traditional medicine practitioner, or modern-medicine doctor who orders the cannabis oil; if symptoms do not improve after follow-up, increase by 1 to 2 drops every 1 week or as that practitioner considers, maximum not more than 20 drops a day; if symptoms improve, reduce by 1 drop every 1 week or as that practitioner considers. Contraindications: history of allergy to a cannabis-extract product or coconut oil; severe or uncontrolled cardiovascular disease; history of psychiatric abnormality; pregnant or breastfeeding woman; a person using warfarin. Cautions: driving, machinery, or dangerous work because of drowsiness; a person under 25 years; liver and kidney disease (liver enzymes more than 3 times the upper normal, or GFR less than 60 millilitres per minute per 1.73 square metres); history of substance use including nicotine, or heavy drinking, a patient using sedatives or other psychoactive medicines, or several chronic medicines. Adverse effects: drowsiness, dry mouth, dizziness, nausea. Additional: if a practitioner considers a dose above the stated maximum, the patient must be followed closely, because there is not yet use and safety data at a higher dose. Management of adverse effects: reduce the dose if dizziness, loss of co-ordination, bradycardia, or abnormal blood pressure; stop at once if disorientation, agitation, anxiety, hallucination, or psychosis.

(3) Cannabis extract oil containing THC and CBD in the ratio 1:1, Group 15. Same formula, condition of who may order, dose, contraindications, warnings, interactions, cautions, and adverse effects as the Group 7 1:1 oil. Indication: adjunct treatment in a patient with terminal cancer who has insomnia, loss of appetite, or moderate-to-severe pain that standard medicine cannot treat or has not treated effectively.


Vol. 140
GOVERNMENT GAZETTE
2 June B.E. 2566
Special Issue 130 Ngor

(4) Cannabis extract oil containing THC, two strengths, Group 15. Same two strengths, formula, dose, contraindications, warnings, interactions, cautions, male-fertility note, and adverse effects as the Group 2.6 nausea oil. Condition: 1. for adjunct treatment in a patient with terminal cancer who has insomnia, loss of appetite, or moderate-to-severe pain that standard medicine cannot treat or has not treated effectively, order by a modern-medicine practitioner who has completed a medical-cannabis training course recognised by the Ministry of Public Health; 2. the 3 milligrams-per-drop strength has the same two sub-conditions as the nausea oil. Indication: that same terminal-cancer adjunct use.

This has not been officially translated. For the exact official text, please refer to the PDF. This is as accurate as possible from our team.

฿395Renewals ฿200Apply for your prescription